FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,607 | -69.8% | 54,531 | -32.1% | 0.00% | – |
| Q2 2023 | $382,286 | -79.9% | 80,312 | -76.0% | 0.00% | -100.0% |
| Q1 2023 | $1,906,136 | +57.7% | 334,410 | +179.2% | 0.00% | – |
| Q4 2022 | $1,208,722 | -49.9% | 119,794 | +11.3% | 0.00% | -100.0% |
| Q3 2022 | $2,412,000 | -20.1% | 107,662 | -11.6% | 0.00% | 0.0% |
| Q2 2022 | $3,019,000 | -26.8% | 121,817 | +14.6% | 0.00% | 0.0% |
| Q1 2022 | $4,123,000 | -30.5% | 106,340 | +4.9% | 0.00% | -50.0% |
| Q4 2021 | $5,934,000 | +6.0% | 101,421 | +7.4% | 0.00% | 0.0% |
| Q3 2021 | $5,596,000 | +13.2% | 94,424 | +65.8% | 0.00% | 0.0% |
| Q2 2021 | $4,944,000 | +16.4% | 56,964 | +10.5% | 0.00% | 0.0% |
| Q1 2021 | $4,249,000 | -10.9% | 51,538 | -1.7% | 0.00% | 0.0% |
| Q4 2020 | $4,768,000 | +151.7% | 52,430 | +10.7% | 0.00% | +100.0% |
| Q3 2020 | $1,894,000 | +143.4% | 47,378 | +109.1% | 0.00% | – |
| Q2 2020 | $778,000 | +58.5% | 22,657 | +2.6% | 0.00% | – |
| Q1 2020 | $491,000 | -19.0% | 22,076 | -28.7% | 0.00% | – |
| Q4 2019 | $606,000 | +43.3% | 30,973 | +13.7% | 0.00% | – |
| Q3 2019 | $423,000 | +94.0% | 27,232 | +153.7% | 0.00% | – |
| Q2 2019 | $218,000 | +5.8% | 10,732 | -8.5% | 0.00% | – |
| Q1 2019 | $206,000 | +41.1% | 11,732 | +3.1% | 0.00% | – |
| Q4 2018 | $146,000 | +16.8% | 11,376 | +48.6% | 0.00% | – |
| Q3 2018 | $125,000 | +43.7% | 7,657 | 0.0% | 0.00% | – |
| Q2 2018 | $87,000 | +4.8% | 7,657 | -10.4% | 0.00% | – |
| Q1 2018 | $83,000 | +72.9% | 8,543 | +9.7% | 0.00% | – |
| Q4 2017 | $48,000 | +118.2% | 7,785 | +38.4% | 0.00% | – |
| Q3 2017 | $22,000 | +22.2% | 5,627 | 0.0% | 0.00% | – |
| Q2 2017 | $18,000 | – | 5,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $131,006,000 | 24.77% |
| Redmile Group, LLC | 12,957,222 | $502,351,000 | 15.68% |
| Grosvenor Holdings, L.L.C. | 1,037,256 | $40,214,000 | 7.85% |
| Casdin Capital, LLC | 3,400,000 | $131,818,000 | 5.91% |
| Ally Bridge Group (NY) LLC | 181,500 | $7,037,000 | 5.22% |
| DAFNA Capital Management LLC | 500,930 | $19,421,000 | 5.06% |
| Deep Track Capital, LP | 2,000,000 | $77,540,000 | 4.97% |
| Artal Group S.A. | 2,000,000 | $77,540,000 | 3.25% |
| Tri Locum Partners LP | 190,345 | $7,380,000 | 2.88% |
| ARK Investment Management | 10,988,182 | $426,012,000 | 1.78% |